TARGETED LIPOSOMAL FORM OF OLIGONUCLEOTIDE-POLYETHYLENEIMINE COMPLEX, ITS USE AND METHOD OF OBTAINING

摘要

The invention relates to the targeted, liposomal form of oligonucleotide-polyethyleneimine complex, characterized in that the oligonucleotide to polyethylenimine ratio ranges from 1:10 to 1:3, and the complex is encapsulated with a lipid bilayer enabling attachment of a targeting molecule recognizing the surface marker of pathological cells, as well as the method of obtaining the same and its application.